ROCKVILLE, MD – July 15, 2019 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; today announced that July 1st, 2019, marked the company’s 25-year anniversary providing CRO services to pharma, biotech, and medical device companies.
DP Clinical was founded in 1994 by Ms. Devinder Poonian in the basement of her house and has organically grown to be a full service CRO in a breadth of therapeutic areas. DP Clinical originally focused on spinal cord injury research and has become a recognized leader in this field. The company later expanded successfully into other therapeutic areas such as cardiology, dermatology, infectious disease, neuroscience, oncology, ophthalmology, rare disease, regenerative medicine, and vaccines. Additionally, DP Clinical has worked on studies involving critical care, pediatrics, and cell therapies.
Company President and CEO, Ms. Devinder Poonian, stated that, "Over the years, DP Clinical has been referred to as a “boutique CRO” because of the high standards of quality, data integrity, and customer service it provides. We achieved this 25-year milestone through the loyalty, hard work, and dedication of our employees who take great pride in what they do; many of whom have been with the company well over 10 years. Without the support of our dedicated team, DPC would not be where it is today. The company has always fostered a culture of client-first service with an emphasis on delivering quality work. DP Clinical has been instrumental in bringing a number of commercial products to market – from development through regulatory approval – including a product now used by my own family member. It is this achievement that reinforces why our role in clinical research is so important and why we devote our resources to assist pharmaceutical, biotechnology, medical device companies as well as academic institutions to find cures for diseases. Lastly, I want to thank all of our clients for giving us the opportunity to work collaboratively on their products – making a difference in the lives of so many people.”
About DP Clinical
DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs. We support pharmaceutical, biotech, and medical device companies in their clinical trial development and execution by providing a full complement of clinical program services including trial management, monitoring, data management, biostatistics, regulatory, safety, and medical writing for commercial, academic, and government Sponsors. For more information, visit the company’s Web site at www.dpclinical.com.
# # #
Press Contact: Mary Lee Keen, Director Marketing